Medication Use during Pregnancy and Lactation: Introducing the Pregnancy and Lactation Labeling Rule

Pediatric, Allergy, Immunology, and Pulmonology

Volumn 30, Issue 2, 2017, Pages 132-134

  Dinatale, Miriam ^a   Sahin, Leyla ^a   Johnson, Tamara ^a   Howard, Tammie Brent ^a   Yao, Lynne ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

breastfeeding; lactation; PLLR; pregnancy; Pregnancy and Lactation Labeling Rule

Indexed keywords

BIOLOGICAL PRODUCT; PRESCRIPTION DRUG;

ARTICLE; DRUG INFORMATION; DRUG LABELING; DRUG USE; HUMAN; LACTATION; PREGNANCY; PRENATAL EXPOSURE; PRESCRIPTION; PRIORITY JOURNAL;

EID: 85021171557     PISSN: 2151321X     EISSN: 21513228     Source Type: Journal    
DOI: 10.1089/ped.2017.0772     Document Type: Article

References (11)

1. Curtin SC, Abma JC, Ventura SJ, Henshaw SK. Pregnancy rates for U. S. women continue to drop. NCHS data brief, no 136. National Center for Health Statistics, 2013. Available at: https://www. cdc. gov/nchs/products/databriefs/db136. htm Accessed May 26, 2017.
2. Mitchell AA, Gilboa SM, Werler MM, et al. Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. Am J Obstet Gynecol 2011; 205:51. e1-51. e8.
3. Center for Disease Control and Prevention. Breastfeeding among U. S. Children Born 2002-2013, CDC National Immunization Survey. Available at: www. cdc. gov/breast feeding/data/nis-data/index. htm. Accessed April 3, 2017.
4. Food and Drug Administration. Pregnancy, lactation, and reproductive potential: labeling for human prescription drug and biological products-content and format: guidance for industry. 2014. Available at: www. fda. gov/downloads/ Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ UCM425398. pdf. Accessed March 23, 2017.
5. Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Final Rule. Federal Registry 2014; 79:72063-72103. Available at: www. gpo. gov/fdsys/pkg/ FR-2014-12-04/pdf/2014-28241. pdf. Accessed March 23, 2017.
6. Pernia S, DeMaagd G. The new pregnancy and lactation labeling rule. Pharm Ther 2016; 41:713-715.
7. Wilmer E, Chai S, Kroumpouzous G. Drug Safety: pregnancy rating classifications and controversies. Clin Dermatol 2016; 34:401-409.
8. Sahin L, Nallani SC, Tassinari MS. Medication use in pregnancy and the pregnancy and lactation labeling rule. Clin Pharmacol Ther 2016; 100:23-25.
9. TassinariM, Sahin L, Yao L. Brief Report: Assessing Congenital Malformation Risk form Medications used in Pregnancy: The Contribution of NBDPS in Pregnancy Labeling of Prescription Drug Products. Birth Defects Res A 2015; 103:718-720.
10. Nucala (mepolizumab). Labeling approved 2/16/2017. Drugs @FDA. gov. Available at: www. Accessdata. fda. gov/ drugsatfda-docs/label/2017/125526s002lbl. pdf. Accessed March 23, 2017.
11. Pandel (hydrocortisone probutate) cream. Labeling approved 1/25/2017. Drugs@FDA. Available at: www. Accessdata. fda. gov/drugsatfda-docs/label/2017/020453s007lbl. pdf. Accessed March 23, 2017.